Pharmaceutical professional with extensive expertise in the pharma sector, specializing in GLP-1 therapies, diabetes, and obesity management. Educational background in Scientific Information on Drugs providing a strong focus on organic chemistry, marketing authorization, and clinical trials. Passionate about international healthcare, demonstrated by pursuit of a 5-year Pharma degree in English, living abroad, and developing bilingual proficiency. Co-founder of a start-up focused on digital marketing, content strategy, and business development, gaining valuable experience in these areas. Experienced pharmacist with a strong foundation in drug dispensation and regulatory compliance. Well-versed in Microsoft Office, CRM tools, and social media platforms, combining analytical thinking with a strategic, patient-centric approach to healthcare solutions. Currently serving as an Obesity Account Specialist at Novo Nordisk, leading new business setup in gynecology and internal medicine, driving market expansion, stakeholder engagement, and scientific education. Previously specialized in GLP-1 drugs for diabetes care, ensuring accurate scientific communication and product adoption among healthcare professionals.
• Built and maintained relantioships with KOLs and HCPs.
• Drove GLP-1 product adoption through strategic business development.
• Collaborated cross-functionally with marketing, medical, and market access teams to optimize GLP-1-focused commercial strategies.
• Analyzed market trends, competitor activity, and prescribing behaviors to enhance GLP-1 drug positioning and sales performance.
Business Development: New market setup, stakeholder engagement, strategic planning, and relationship management with KOLs
Scientific Engagement & Training: Medical education, workshops, advisory boards for HCPs
Commercial Strategy: Cross-functional collaboration with marketing, medical affairs, and market access
Market & Competitor Analysis: Industry trends, competitor activities, treatment adoption
Soft Skills: Strong strategic thinking and decision making approach, problem-solving, adaptability and resilience in dynamic markets
Open to be relocated